Type in a drug name to check for interactions with hydroxychloroquine. View interaction reports for hydroxychloroquine and the medicines listed below. The relevance of a particular drug interaction to a specific individual is difficult to determine. Plaquenil anti inflammatory mechanism Abcc1 transporter chloroquine What does plaquenil do to the eyes Azithromycin Major Avoid coadministration of hydroxychloroquine and azithromycin. Hydroxychloroquine increases the QT interval and should not be administered with other drugs known to prolong the QT interval. Ventricular arrhythmias and torsade de pointes TdP have been reported with the use of hydroxychloroquine. Hydroxychloroquine and Surfactant Protein C Deficiency This article has no abstract; the first 100 words appear below. To the Editor We wish to report initial success in treating a boy with. Azithromycin is used to treat a wide variety of bacterial infections. It is a macrolide-type antibiotic. It works by stopping the growth of bacteria. Read the Patient Information Leaflet if. A drug originally developed to treat malaria is showing signs that it may also cure infections of the coronavirus, though much more testing is needed. Always consult your healthcare provider before starting or stopping any medication. Hydroxychloroquine and azithromycin RA and Hydroxychloroquine How Effective is it for., Hydroxychloroquine and Surfactant Protein C Deficiency NEJM Optometrist letter to primary care physician plaquenil Liver disease with prior azithromycin use, history of—Should not be used in patients with this condition. Bacteremia blood infection or Cystic fibrosis or Infections, nosocomial or hospital-acquired or Weak immune system or Weakened physical condition—Zithromax® should not be used in patients with these conditions to treat pneumonia. Azithromycin Oral Route Before Using - Mayo Clinic. Azithromycin Oral Uses, Side Effects, Interactions.. Hydroxychloroquine - Wikipedia. Hydroxychloroquine and azithromycin as a treatment of COVID-19 results of an open-label non-randomized clinical trial Gautret et al. preprint PDF Academic Report. A total of 26 patients received hydroxychloroquine and 16 were control patients. 6 patients in treatment arm were removed 3 went to ICU, 1 died, 2 stopped treatment. The results presented here are therefore those of 36 patients 20 hydroxychloroquine-treated patients and 16 control patients. Hydroxychloroquine/QT Prolonging Agents Interactions. This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment.